Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Jun-24 4:35 PM View:  | Orthofix International NV (OFIX) | 10-Jun-24 | Grant | 14,401 | $13.02 | $187,501.00 | 100% 0 to 14.4K | |
| 07-Jun-23 9:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,099 | $37.87 | $41,613.60 | (4%) 30.32K to 29.23K | |
| 07-Jun-23 9:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,054 | $38.99 | $41,096.50 | (3%) 31.38K to 30.32K | |
| 11-Oct-22 4:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Oct-22 | Market Sale (Planned) | 1,380 | $58.00 | $80,040.00 | (4%) 32.76K to 31.38K | (6%) |
| 08-Jun-22 7:40 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 7,950 | -- | -- | 33% 24.3K to 32.25K | |
| 08-Jun-22 7:40 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-22 | Market Sale (Planned) | 2,433 | $62.00 | $150,846.00 | (9%) 26.83K to 24.4K | 1% |
| 08-Jun-22 7:40 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Market Sale | 2,817 | $61.37 | $172,891.00 | (10%) 29.65K to 26.83K | < 1% |
| 25-Apr-22 4:12 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 21-Apr-22 | Option Exercise | 12,500 | $42.54 | $531,750.00 | 46% 26.97K to 39.47K | |
| 25-Apr-22 4:12 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 21-Apr-22 | Planned Option Sale | 9,824 | $73.25 | $719,647.00 | (25%) 39.47K to 29.65K | |
| 20-Apr-22 8:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 20-Apr-22 | Option Exercise | 12,500 | $42.54 | $531,750.00 | 52% 24.24K to 36.74K | |
| 20-Apr-22 8:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 20-Apr-22 | Planned Option Sale | 9,764 | $73.99 | $722,438.00 | (27%) 36.74K to 26.97K | |
| 20-Apr-22 8:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 19-Apr-22 | Option Exercise | 12,500 | $42.54 | $531,750.00 | 59% 21.06K to 33.56K | |
| 20-Apr-22 8:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 19-Apr-22 | Planned Option Sale | 9,321 | $72.25 | $673,442.00 | (28%) 33.56K to 24.24K | |
| 20-Apr-22 8:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 18-Apr-22 | Option Exercise | 12,500 | $42.54 | $531,750.00 | 71% 17.5K to 30.0K | |
| 20-Apr-22 8:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 18-Apr-22 | Planned Option Sale | 8,941 | $73.55 | $657,611.00 | (30%) 30.0K to 21.06K | |
| 11-Jun-21 8:40 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 7,000 | -- | -- | 67% 10.5K to 17.5K | |
| 08-Jun-21 4:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-21 | Market Sale (Planned) | 2,278 | $60.50 | $137,819.00 | (18%) 12.78K to 10.5K | (2%) |
| 08-Jun-21 4:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-21 | Market Sale | 1,222 | $61.04 | $74,587.20 | (9%) 14.0K to 12.78K | (1%) |
| 08-Jan-21 4:39 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jan-21 | Market Sale (Planned) | 110 | $60.81 | $6,689.10 | (< 1%) 14.11K to 14.0K | (11%) |
| 17-Nov-20 5:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Nov-20 | Option Exercise | 25,000 | $42.54 | $1,063,500.00 | 179% 14.0K to 39.0K | 4% |
| 17-Nov-20 5:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Nov-20 | Market Option Sale (Planned) | 25,000 | $63.38 | $1,584,390.00 | (64%) 39.0K to 14.0K | 7% |
| 21-Sep-20 6:23 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Sep-20 | Option Exercise | 25,000 | $42.54 | $1,063,500.00 | 173% 14.42K to 39.42K | 4% |
| 21-Sep-20 6:23 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Sep-20 | Market Option Sale (Planned) | 25,000 | $59.81 | $1,495,200.00 | (63%) 39.42K to 14.42K | < 1% |
| 21-Sep-20 6:23 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Sep-20 | Market Sale (Planned) | 420 | $59.81 | $25,119.30 | (3%) 14.42K to 14.0K | < 1% |
| 11-Jun-20 6:31 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 14,000 | -- | -- | 100% 0 to 14.0K |